Plasma hPG(80) (Circulating Progastrin) as a Novel Prognostic Biomarker for early-stage breast cancer in a breast cancer cohort

BACKGROUND: Recurrence and metastases are still frequent outcomes after initial tumour control in women diagnosed with breast cancer. Although therapies are selected based on tumour characteristics measured at baseline, prognostic biomarkers can identify those at risk of poor outcomes. Circulating p...

Descripción completa

Detalles Bibliográficos
Autores principales: Prieur, Alexandre, Harper, Andrew, Khan, Momtafin, Vire, Bérengère, Joubert, Dominique, Payen, Léa, Kopciuk, Karen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071601/
https://www.ncbi.nlm.nih.gov/pubmed/37016331
http://dx.doi.org/10.1186/s12885-023-10729-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071601/
https://www.ncbi.nlm.nih.gov/pubmed/37016331
http://dx.doi.org/10.1186/s12885-023-10729-1

Ejemplares similares